Alejo Rodriguez-Vida

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Topics

Prognostic Factors

Metastatic Renal Cell Carcinoma

Top Venues

Science translational medicine

BJU international

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Cristina Suárez, James M G Larkin, Poulam Patel, Begoña P Valderrama, Alejo Rodriguez-Vida, Hilary Glen, Fiona Thistlethwaite, Christy Ralph, Gopalakrishnan Srinivasan, Maria Jose Mendez, Ryan Hartmaier, Aleksandra Markovets, Aaron Prendergast, Bernadett Szabados, Kelly Mousa, Thomas Powles
Phase II Study Investigating the Safety and Efficacy of Savolitinib and Durvalumab in Metastatic Papillary Renal Cancer (CALYPSO). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Laura Segalés, Nuria Juanpere-Rodero, Nerea Gallarín, Marta Lorenzo, David López, Júlia Perera-Bel, Alejo Rodriguez-Vida, Lluis Fumadó, Lluís Cecchini, Joaquim Bellmunt, Josep Lloreta-Trull, Silvia Hernández-Llodrà
Immunohistochemical markers as predictors of prognosis in multifocal prostate cancer. Virchows Archiv : an international journal of pathology (2023)
Pauline Parent, Edouard Auclin, Anna Patrikidou, Laura Mezquita, Nieves Martínez Chanzá, Clément Dumont, Alejo Rodriguez-Vida, Casilda Llácer Pérez, Rebeca Lozano, Raffaele Ratta, Axel S Merseburger, Cora N Sternberg, Giulia Baciarello, Emeline Colomba, Alina Fuerea, Benjamin Besse, Yohann Loriot, Pernelle Lavaud
Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma. Cancers 15 (4) (2023)
Ignacio Melero Bermejo, Tamara Tanos, Mariana Bustamante, Miguel F Sanmamed, Emiliano Calvo, Irene Moreno-Candilejo, Victor Moreno, Tatiana Hernández, Maria Martinez-García, Alejo Rodriguez-Vida, Josep Tabernero, Analia Azaro, Mariano Ponz-Sarvisé, Iben Spanggaard, Kristoffer Staal Rohrberg, Ernesto Guarin, Eveline Nüesch, Iakov I Davydov, Chia-Huey Ooi, José Duarte, Evelyne Chesne, Christine McIntyre, Maurizio Ceppi, Marta Cañamero, Oliver Krieter
A first-in-human study of the fibroblast activation protein-targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors. Science translational medicine 15 (695) (2023)
Ignacio Melero Bermejo, Tamara Tanos, Mariana Bustamante, Miguel F Sanmamed, Emiliano Calvo, Irene Moreno-Candilejo, Victor Moreno, Tatiana Hernández, Maria Martinez-García, Alejo Rodriguez-Vida, Josep Tabernero, Analia Azaro, Mariano Ponz-Sarvisé, Iben Spanggaard, Kristoffer Staal Rohrberg, Ernesto Guarin, Eveline Nüesch, Iakov I Davydov, Chia-Huey Ooi, José Duarte, Evelyne Chesne, Christine McIntyre, Maurizio Ceppi, Marta Cañamero, Oliver Krieter
A first-in-human study of the fibroblast activation protein-targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors. Science translational medicine 15 (695) (2023)
Pauline Parent, Edouard Auclin, Anna Patrikidou, Laura Mezquita, Nieves Martínez Chanzá, Clément Dumont, Alejo Rodriguez-Vida, Casilda Llácer Pérez, Rebeca Lozano, Raffaele Ratta, Axel S Merseburger, Cora N Sternberg, Giulia Baciarello, Emeline Colomba, Alina Fuerea, Benjamin Besse, Yohann Loriot, Pernelle Lavaud
Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma. Cancers 15 (4) (2023)
Pauline Parent, Edouard Auclin, Anna Patrikidou, Laura Mezquita, Nieves Martínez Chanzá, Clément Dumont, Alejo Rodriguez-Vida, Casilda Llácer Pérez, Rebeca Lozano, Raffaele Ratta, Axel S Merseburger, Cora N Sternberg, Giulia Baciarello, Emeline Colomba, Alina Fuerea, Benjamin Besse, Yohann Loriot, Pernelle Lavaud
Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma. Cancers 15 (4) (2023)
Alejo Rodriguez-Vida, Aristotelis Bamias, Emilio Esteban, Maria Isabel Saez, Marta Lopez-Brea, Daniel Castellano, Cristina Caballero, Jose Luis Gonzalez-Larriba, Emiliano Calvo, Sonia Macia, Alain Ravaud, Joaquim Bellmunt
Randomised Phase II study comparing alternating cycles of sunitinib and everolimus vs standard sequential administration in first-line metastatic renal carcinoma (SUNRISES study). BJU international 126 (5) (2020)